Free Trial

Abrdn Life Sciences Investors (HQL) Competitors

$13.05
-0.17 (-1.29%)
(As of 05/29/2024 ET)

HQL vs. CET, QQQX, GAM, MUC, MFIC, SLRC, MQY, HQH, MYI, and PHK

Should you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Central Securities (CET), Nuveen Nasdaq 100 Dynamic Overwrite Fund (QQQX), General American Investors (GAM), BlackRock MuniHoldings California Quality Fund (MUC), MidCap Financial Investment (MFIC), SLR Investment (SLRC), BlackRock MuniYield Quality Fund (MQY), Abrdn Healthcare Investors (HQH), BlackRock MuniYield Quality Fund III (MYI), and PIMCO High Income Fund (PHK). These companies are all part of the "investment offices, not elsewhere classified" industry.

Abrdn Life Sciences Investors vs.

Abrdn Life Sciences Investors (NYSE:HQL) and Central Securities (NYSE:CET) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, community ranking, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abrdn Life Sciences Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Central Securities
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Abrdn Life Sciences Investors has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Central Securities has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
Abrdn Life Sciences InvestorsN/A N/A N/A
Central Securities N/A N/A N/A

In the previous week, Abrdn Life Sciences Investors had 1 more articles in the media than Central Securities. MarketBeat recorded 5 mentions for Abrdn Life Sciences Investors and 4 mentions for Central Securities. Abrdn Life Sciences Investors' average media sentiment score of 0.88 beat Central Securities' score of 0.08 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abrdn Life Sciences Investors
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Central Securities
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Life Sciences Investors$23.52M15.17N/AN/AN/A
Central SecuritiesN/AN/AN/AN/AN/A

32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 8.7% of Central Securities shares are held by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are held by insiders. Comparatively, 10.3% of Central Securities shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users.

CompanyUnderperformOutperform
Abrdn Life Sciences InvestorsOutperform Votes
95
68.35%
Underperform Votes
44
31.65%
Central SecuritiesN/AN/A

Abrdn Life Sciences Investors pays an annual dividend of $1.49 per share and has a dividend yield of 11.4%. Central Securities pays an annual dividend of $1.85 per share and has a dividend yield of 4.4%.

Summary

Abrdn Life Sciences Investors beats Central Securities on 6 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HQL vs. The Competition

MetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE Exchange
Market Cap$356.93M$7.20B$9.05B$17.46B
Dividend Yield11.09%6.21%10.25%3.53%
P/E RatioN/A0.4555.9325.52
Price / Sales15.1718.163,511.3610.11
Price / CashN/A7.8327.7119.29
Price / BookN/A0.993.115.82
Net IncomeN/A$73.96M$1.01B$975.72M
7 Day Performance-3.12%-0.93%-0.61%-0.51%
1 Month Performance-0.46%1.21%1.64%2.67%
1 Year Performance-0.61%5.18%16.17%22.10%

Abrdn Life Sciences Investors Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CET
Central Securities
0 of 5 stars
$43.15
+0.8%
N/AN/A$1.23BN/A0.00N/A
QQQX
Nuveen Nasdaq 100 Dynamic Overwrite Fund
0 of 5 stars
$24.04
+0.6%
N/A-4.9%$1.17BN/A0.00N/APositive News
GAM
General American Investors
0 of 5 stars
$48.16
+0.8%
N/A+20.0%$1.15BN/A0.00N/AShort Interest ↑
News Coverage
MUC
BlackRock MuniHoldings California Quality Fund
0 of 5 stars
$10.91
+0.8%
N/A+3.4%$1.05BN/A0.00147,000Short Interest ↑
News Coverage
MFIC
MidCap Financial Investment
0.7916 of 5 stars
$15.47
+1.2%
$15.04
-2.8%
+33.4%$1.01B$276.52M8.84N/APositive News
SLRC
SLR Investment
1.7844 of 5 stars
$16.29
+1.2%
$14.80
-9.1%
+16.0%$888.78M$229.31M9.15N/AShort Interest ↓
Positive News
MQY
BlackRock MuniYield Quality Fund
0 of 5 stars
$12.10
+1.0%
N/A+6.5%$884.27MN/A0.00N/AShort Interest ↓
Positive News
HQH
Abrdn Healthcare Investors
0 of 5 stars
$16.69
+0.4%
N/A-2.4%$844.85MN/A0.00147,000Short Interest ↑
News Coverage
Negative News
MYI
BlackRock MuniYield Quality Fund III
0 of 5 stars
$11.07
+0.5%
N/A+2.1%$753.42MN/A0.00147,000Short Interest ↑
Negative News
PHK
PIMCO High Income Fund
0 of 5 stars
$4.80
+0.2%
N/A+1.9%$701.42MN/A0.00147,000Short Interest ↑
News Coverage

Related Companies and Tools

This page (NYSE:HQL) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners